experi
imol
immunolog
reaction
graft
neuronnl
tissu
success
graft
homotop
tissu
see
tabl
terminolog
ie
neuron
tissu
brain
recent
increas
interest
brain
immunolog
privileg
transplant
site
evid
accumul
past
decad
demonstr
optim
condit
neuron
graft
seem
abl
surviv
indefinit
appear
becom
integr
host
brain
extent
form
synapt
connect
normal
behavior
biochem
chang
due
prior
experiment
damag
host
brain
connect
review
see
ref
attempt
neuron
graft
perform
inbr
strain
rodent
donorhost
combin
transplant
antigen
differ
thu
avoid
complex
immunolog
reaction
therefor
studi
intracerebr
neuron
graft
realli
address
issu
immunolog
reject
brain
possibl
revers
mani
behavior
deficit
anim
model
neurolog
diseas
parkinson
diseas
pd
focus
attent
use
neuron
graft
amelior
clinic
manifest
neuron
major
neuropatholog
featur
pd
death
dopamin
da
contain
neuron
sub
celi
surfac
molecul
express
interindividu
variabl
induc
reject
sometim
process
aiation
host
major
histompat
complex
antigen
graft
tissu
within
one
individu
transplant
genet
ident
individu
often
inbr
strain
ident
twin
transplant
genet
differ
individu
within
speci
transplant
differ
speci
transplant
tissu
normal
locat
eg
skin
skin
transplant
tissu
abnorm
locat
eg
skin
brain
stantia
inde
result
clinic
trial
involv
transplant
brain
pd
patient
alreadi
publish
sever
studi
underway
trial
graft
tissu
neuron
origin
consist
endocrin
catecholamineproduc
cell
adren
medulla
patient
autolog
graft
see
tabl
addit
publish
case
knowledg
least
patient
undergon
surgic
procedur
autolog
adren
medullari
tissu
wherea
autograft
procedur
avoid
problem
immunolog
reject
studi
experiment
anim
indic
adren
medulla
graft
possess
function
capac
neuron
graft
contain
da
therefor
interest
seek
sourc
neuron
donor
tissu
graft
pd
patient
also
neurolog
diseas
tissu
avail
substitut
neurotransmitt
lost
diseas
process
intraparench
graft
da
neuron
adult
brain
seem
requir
donor
tissu
fetal
immatur
good
surviv
suitabl
donor
tissu
graft
pd
patient
may
thu
consist
immatur
mesencephal
da
neuron
abort
human
fetus
inevit
tissu
immunolog
incompat
pd
patient
therefor
clear
understand
immunolog
brain
becom
increasingli
import
futur
object
paper
briefli
review
technic
approach
success
transplant
neuron
tissu
focu
immunolog
aspect
graft
incompat
tissu
brain
special
refer
immunolog
problem
face
futur
clinic
applic
techniqu
patient
pd
although
sever
studi
shown
immunolog
incompat
tissu
surviv
graft
brain
littl
known
law
govern
graft
surviv
condit
discuss
possibl
underli
reason
immunolog
privileg
brain
limit
privileg
site
like
sequenc
cellular
event
entri
alloxenogen
tissu
brain
use
immunosuppress
prevent
graft
reject
final
present
hypothesi
immun
reaction
regul
within
brain
tissu
one
propos
simpl
basic
neurobiolog
condit
need
fulfil
obtain
optim
surviv
function
neuron
graft
experiment
anim
cf
tabl
ix
part
gener
donor
tissu
must
immatur
fetal
neonat
transplant
surgeri
conduct
asept
condit
furthermor
good
intraparenchym
graft
surviv
requir
transplant
rapidli
vascular
host
limit
size
graft
piec
moreov
studi
clearli
indic
axon
outgrowth
transplant
tissu
extens
place
within
reach
natur
anatom
target
region
brain
eg
graft
da
neuron
sever
differ
methodolog
approach
use
experiment
neuron
graft
research
ie
transplant
solid
fetal
neonat
central
nervou
system
cn
tissu
surgic
prepar
caviti
transplant
solid
fetal
neonat
tissu
directli
brain
parenchyma
ventricular
space
final
implant
cell
suspens
prepar
fetal
tissu
brain
parenchyma
extens
studi
fetal
neuron
graft
anterior
chamber
theey
immunolog
statu
site
differ
braint
l
sinc
anterior
chamber
eye
true
cn
site
studi
includ
review
differ
method
transplant
site
differ
aspect
probabl
relev
immunolog
reaction
graft
tissu
systemat
studi
directli
compar
result
use
differ
transplant
site
techniqu
donorrecipi
combin
given
immunogenet
differ
exampl
reason
solid
graft
place
prepar
caviti
cortex
cover
pial
scar
sourc
vascular
ident
point
view
origin
vessel
possibl
also
bloodbrain
barrier
properti
graft
dissoci
neuron
tissu
implant
directli
striatum
moreov
ventricular
space
may
also
present
somewhat
diffet
iminunologicai
situat
compar
graft
brain
parenchyma
mention
section
small
piec
develop
neuron
tissu
insert
directli
brain
parenchyma
solid
piec
use
wide
glass
metal
approach
give
access
deep
brain
site
also
ventricular
howev
techniqu
limit
yield
reproduc
good
graft
surviv
brain
parenchyma
recipi
neonat
young
thu
suitabl
investig
immunolog
aspect
neuron
graft
sinc
neonat
host
day
age
possess
immatur
immun
system
therefor
immunolog
unrespons
toler
might
develop
larger
solid
piec
cn
tissu
surviv
adult
host
excel
growth
place
surgic
prepar
caviti
line
either
natur
vascular
bed
well
vascular
pial
scar
tissu
techniqu
access
limit
brain
structur
near
surfac
brain
graft
deeper
brain
structur
would
requir
rcmoval
excess
amount
host
brain
cell
suspens
neuron
graft
techniyu
larg
circumv
problem
limit
anatom
access
allow
graft
tissu
stereotaxit
microinject
almost
site
cn
basic
version
method
fetal
cn
tissu
first
incub
trypsin
rins
repeatedli
mechan
dissoci
repeat
pass
tip
firepolish
pasteur
pipett
due
dissoci
trauma
cell
suspens
techniqu
impos
greater
constraint
donorag
tissu
mani
region
cn
exampl
graft
rat
mesencephalit
da
neuron
donor
fetu
ought
day
gestationai
age
otherwis
littl
da
neuron
surviv
obtain
h
similarli
poor
surviv
graft
human
da
neuron
obtain
human
donor
fetus
older
approxim
week
postconcept
aforement
graft
techniqu
caus
damag
host
brain
concomit
ruptur
fi
microgbbulin
fig
schemat
draw
possibl
target
immunolog
reaction
prime
target
immun
respons
ailagen
graft
situat
mhc
class
ii
molecul
membranebound
glycoprotein
may
display
interindividu
polymorph
ia
thyl
distribut
least
man
rat
mous
mrc
medic
research
council
monoclon
bank
describ
rat
ncam
neuroncel
adhes
molecul
speci
ncp
neurocytoplasm
protein
far
found
rat
base
ref
bioodbrain
barrier
nonetheless
extent
inammatori
respons
elicit
differ
techniqu
vari
due
differ
degre
host
brain
damag
follow
section
outlin
basic
principl
immunolog
relev
transplant
brain
order
limit
review
disregard
common
concept
brain
possess
separ
immun
system
clear
lymphocyt
within
brain
tissu
origin
outsid
brain
either
precursor
might
give
rise
clone
within
brain
tissu
matur
precomit
one
import
properti
immun
system
abil
distinguish
self
nonself
structur
subsequ
inactiv
perceiv
nonself
import
structur
discrimin
self
versu
nonself
membranebound
glycoprotein
encod
major
histocompat
gene
complex
major
histocompat
complex
mhc
compris
gene
foci
give
rise
class
ii
iii
antigen
class
ii
cell
surfac
glycoprotein
display
high
degre
polymorph
ie
interindidu
differ
serv
guidanc
recognit
molecul
immun
system
class
iii
molecul
low
degre
polymorph
found
blood
complement
factor
strong
transplant
antigen
mhc
class
ii
gene
product
class
mhc
molecul
form
complex
nonvari
microglobulin
mous
mhc
class
structur
littl
polymoh
hitherto
consid
play
minor
role
regul
immun
reaction
molecul
encod
mhc
region
call
tla
gene
mous
qa
gene
mous
role
molecul
immun
system
incomplet
understood
distribut
homologu
structur
speci
larg
unknown
class
antigen
hla
b
c
rtla
e
k
class
ii
antigen
hlado
dp
rtlb
hz
ie
ia
dq
dr
base
ref
mhc
see
fig
tabl
ii
immun
system
potent
capac
react
foreign
antigen
nonself
structur
format
antibodi
humor
respons
gener
effector
cell
helper
tcell
killer
tcell
cellmedi
respons
delay
type
hypersensit
dth
cytotox
blymphocyt
form
antibodi
virtual
structur
even
complet
synthet
molecul
repertoir
antigen
tlymphocyt
respond
slightli
narrow
clone
tcell
ontogenetit
direct
individu
cell
select
elimin
develop
immun
respons
eg
graft
reject
occur
immun
system
activ
rest
normal
state
gener
tcell
becom
activ
foreign
antigen
must
associ
mhc
molecul
bind
tcell
receptor
case
transplant
reaction
tcell
receptor
bind
mhc
molecul
cell
surfac
graft
tissu
directli
activ
lead
product
effector
mechan
cell
help
cell
kill
antibodi
format
bcell
effector
mechan
develop
immun
taken
place
select
featur
function
antigen
specif
cell
lymphocyt
summar
tabl
iiia
sever
cell
without
antigenspecif
recognit
capabl
take
part
activ
process
call
accessori
cell
immun
system
function
accessori
cell
summar
tabl
iiib
activ
cell
immun
system
produc
lymphokin
substanc
particip
regul
immun
reaction
mani
molecul
known
sever
year
includ
interleukin
ill
yinterferon
ifn
sever
new
impoant
lymphokin
recent
describ
sequenc
includ
ref
ref
ref
log
alymphotoxin
alt
tumor
necrosi
factora
tnfa
propos
effect
sourc
lymphokin
summar
tabl
iv
commonli
occur
rout
activ
normal
immun
respons
start
antigen
taken
accessori
cell
eg
macrophag
subsequ
antigen
either
directli
associ
mhc
class
ii
molecul
cell
surfac
antigen
broken
smaller
piec
cell
anrigen
procesiag
associ
mhc
class
ii
molecul
surfac
antigenpres
cellist
conjunct
present
antigen
accessori
cell
also
stimul
produc
thought
import
helper
tcell
prolifer
earli
stage
immun
activ
howev
may
well
absolut
necessari
prolifer
occur
like
sole
stimul
factor
helper
tcell
constitut
one
two
main
subciass
tcell
differ
mode
activ
helper
tcell
usual
becom
activ
antigen
present
togeth
self
mhc
class
ii
structur
wherea
kifler
tcell
activ
antigen
bound
self
mhc
class
target
cell
concept
call
mhc
restrit
helper
tcell
key
cell
provid
necessari
lymphokin
cell
immun
system
regul
differenti
growth
subdivis
helper
tcell
base
lymphokin
secret
pre
phenotyp
given
matur
rest
cell
function
activ
either
antigen
alon
help
tcell
subgroup
helper
tcell
ubiquit
accept
statu
suppressor
cell
also
debat
infoat
given
clarif
text
regard
authorit
abbrevi
use
tabl
iiia
b
iv
adcc
antibodydepend
cellular
cytotox
kill
cell
immunoglobulin
bound
receptor
killer
cell
target
cell
cell
express
surfac
marker
denot
eg
cell
neg
marker
eg
cd
cluster
differenti
structur
similar
function
properti
cell
differ
speci
activ
molecul
tcell
use
marker
matur
tcell
abl
respond
antigen
molecul
bind
mhc
antigen
class
ii
molecul
bind
mhc
antigen
class
igag
immun
complex
ij
propos
gener
accept
marker
subtyp
tcell
abil
regul
immun
reaction
lak
lymphokin
activ
killer
cell
nk
cell
expand
repertoir
celltarget
treatment
lp
lipolysacchad
bacteri
product
activ
murin
bcell
macrophag
ltx
leukotrien
nklt
natur
kifler
cell
lymphoton
pg
prostaandin
sig
surfacebound
immogiobuiin
helpert
cell
cytotox
tcell
tcell
receptor
class
mhc
restrict
cytotox
suppressor
tcell
receptor
complex
unknown
entiti
separ
restrict
pattern
unknown
cell
popul
regul
immun
reaction
disput
antigenspecif
manner
antigenspecif
suppressor
factor
propos
none
sequenc
cise
function
recent
initi
step
activ
thelper
lymphocyt
foreign
antigen
associ
mhc
class
ii
molecul
surfac
antigenpres
cell
helper
tcell
bind
antigenmhc
class
ii
molecul
complex
tcell
receptor
tcell
recognit
structur
foreign
antigen
interact
lead
unknown
activ
signai
helper
tcell
cell
start
produc
precursor
killer
tcell
nonactiv
killer
tcell
bind
antigenpres
cell
foreign
antigen
mhc
class
molecul
also
form
complex
secret
helper
tcell
stimul
precursor
killer
tcell
prolifer
matur
effector
killer
tcell
fig
outlin
step
normal
activ
immun
system
result
proiifer
helper
tcell
killer
tcell
altern
rout
activ
possibl
foreign
cell
possess
mhc
molecul
somewhat
similar
yet
differ
host
often
occur
transplant
situat
condit
tcell
may
partial
recogn
mhc
molecul
bound
foreign
antigen
consid
mhc
molecul
associ
foreign
antigen
ident
host
mhc
percept
alteredself
lead
activ
immun
system
outlin
fig
gener
rule
transplant
whenev
graft
cell
surfac
structur
transplant
antigen
recipi
celi
share
graft
reject
nonimmun
adult
host
rapid
reject
found
graft
incompat
regard
major
transplant
antigen
mhc
class
class
ii
antigen
therefor
structur
sometim
call
strong
transplant
antigen
rodent
orthotopi
graft
skin
typic
reject
day
strong
transplant
antigen
differ
graft
recipi
differ
nonmhc
structur
minor
weak
transplant
antigen
surviv
time
skin
graft
may
vari
quantit
domin
mode
activ
immun
system
graft
strain
speci
allogen
graft
possibl
also
speci
xenogen
graft
due
fig
precursor
cell
immun
system
react
antigen
allograft
antigen
gener
accept
interpret
find
host
immun
system
recogn
structur
graft
cell
alteredself
structur
sinc
tcell
repertoir
evolv
react
toward
selfmhc
molecul
carri
foreign
antigen
thymu
delet
selfreact
clone
howev
clone
reactiv
alloantigen
unaffect
thymu
process
addit
allogen
mhc
assum
resembl
selfmhc
bound
sever
differ
antigen
recognit
alteredself
structur
alloantigen
lead
strong
immunolog
helper
tcell
helper
spons
principl
ident
immun
respons
virusinfect
prolifer
host
helper
tcell
greatli
enhanc
ill
produc
donorderiv
antigen
present
cell
call
passeng
leukocyt
cell
capabl
produc
ill
also
possess
high
level
mhc
class
ii
thought
strongest
stimulu
reject
like
mode
activ
immun
system
allograft
situat
summar
fig
donor
antigenpres
cell
pick
foreign
antigen
present
caus
graft
reject
fig
antigenpres
cell
may
locat
graftbear
tissu
resid
antigenpres
cell
lymphat
tissu
drain
graft
area
order
reach
lymphat
tissu
graft
antigen
either
flow
free
fluid
phase
region
lymphat
tissu
bind
resid
antigenpres
cell
turn
migrat
region
lymphat
tissu
antigen
associ
host
mhc
class
ii
antigen
possibl
antigen
process
also
present
lymphocyt
propos
nonmhc
transplant
antigen
may
process
order
caus
reject
wherea
minor
transplant
antigen
requir
process
xenograft
combin
immunolog
reaction
necessarili
domin
antimhc
reactiv
although
like
import
antigen
stimulu
support
mhc
reactiv
xenograft
sach
et
al
found
antibodi
reactiv
speciesspecif
mhc
epitop
also
strainspecif
mhc
epitop
rat
immun
mous
cell
howev
also
conceiv
nonmhc
antigen
may
play
import
role
xenograft
allograft
determin
graft
surviv
empir
data
shown
surviv
time
xenograft
often
alway
rel
short
apart
strain
immunodefici
mammalian
speci
complet
graft
reject
capac
howev
certain
hostrecipi
combin
may
variat
graft
surviv
time
depend
actual
combin
graft
strain
b
may
surviv
long
time
wherea
graft
b
graft
onto
may
surviv
shorter
time
howev
case
rare
occur
inbr
strain
outbr
strain
paradigm
appli
reject
capac
usual
intact
unless
anim
compromis
diseas
transplant
law
summar
tabl
v
spite
decad
interest
reject
mechan
graft
real
consensu
exactli
cell
necessari
reject
process
sever
recent
review
discuss
topic
great
detail
knowledg
cellular
reaction
underli
immunolog
reject
might
provid
mean
develop
specif
less
toxic
gener
rule
transplant
whenev
donor
tissu
possess
cell
surfac
structur
transplant
antigen
h
gene
locu
fat
transplant
antigen
recipi
share
graft
reject
swgeneicgruft
graft
individu
inbr
strain
surviv
anir
px
ffr
graft
differ
inbr
strain
fail
xenugeneicgrqfi
graft
differen
speci
fail
graft
male
femal
within
inbr
strain
transplant
antigen
ident
may
reject
multipl
histocompat
differ
addit
similar
strength
pronounc
minor
transplant
antigen
differ
transplant
antigen
codomin
fi
hybrid
express
allel
h
locu
skin
graft
incompat
class
andor
ii
mhc
structur
reject
within
day
mous
skin
graft
differ
one
nonmhc
transplant
antigen
host
donor
may
reject
day
mous
allograft
surviv
time
directli
proport
graft
size
except
known
weaker
histocompat
differ
longer
graft
surviv
larg
graft
weaker
histocompat
differ
onset
reject
delay
durat
longer
ie
prolong
time
reject
immunolog
memori
stronger
shortterm
durat
weaker
hstocompat
differ
eas
ref
way
interf
reject
process
analysi
event
lead
reject
graft
tissu
exampl
done
transfer
differ
cell
popul
anim
bear
graft
howev
even
studi
controversi
continu
concern
minimum
requir
cell
pop
ulat
necessari
transfer
order
induc
graft
reject
activ
killer
tcell
immun
anim
transfer
anim
bear
graft
tissu
wili
caus
helper
tcell
transfer
host
graft
graft
promptli
reject
possibl
recruit
host
killer
tceil
mediat
actual
graft
reject
combin
helper
killer
tcell
transfer
graft
reject
usual
also
prompt
addit
specif
cellmedi
respons
discuss
rather
unspecif
inflammatori
compon
probabl
also
particip
reject
process
socal
delayedtyp
mediat
activ
helper
tcell
produc
lymphokin
yifn
al
lymphokin
caus
intens
inamm
monocytieukoc
aggreg
direct
cellular
cytotox
may
result
kill
graft
tissu
also
normal
healthi
cell
may
kill
bystanderkil
thu
dth
regard
harm
organ
claim
made
privileg
site
protect
dth
reaction
unknown
mechan
dth
reaction
occur
place
believ
particularli
harm
apart
toxin
releas
lymphocyt
macrophag
oligodendro
helper
tcell
provid
killer
tcell
helper
tcell
may
produc
lymphokin
directli
cytotox
target
cell
iii
helper
tcell
possibl
via
yif
n
lymphokin
may
chemotact
inflammatori
cell
macrophag
activ
yii
stimuli
cytotox
immunoglobulin
may
bind
macrophag
target
cell
antibodi
depend
cellular
cytolysi
adcc
may
take
place
iv
antibodi
may
caus
cytotox
complement
bind
cyte
cytotox
factor
releas
activ
astrocyt
describ
vitro
import
stress
even
dth
reaction
initi
elicit
event
involv
specif
recognit
graft
exist
complet
unspecif
mechan
graft
destruct
role
antibodi
graft
reject
remain
unceain
antibodi
bind
surfac
cell
foreign
antigen
certain
condit
bind
circul
complement
factor
caus
cellular
lysi
target
cell
macrophag
monocyt
possibl
natur
killer
cell
socal
null
cell
receptor
constant
part
immunoglobulin
f
attach
antibodi
bound
graft
cell
graft
cell
subsequ
kill
process
call
antibodydepend
cellular
cytotox
adc
phenomenon
well
describ
vitro
role
adcc
vivo
remain
determin
hyperacut
reject
graft
reject
within
h
preimmun
anim
mediat
mainli
antibodi
possibl
certain
case
xenograft
absenc
immun
preform
antibodi
direct
graft
tissu
present
host
graft
thought
lower
surviv
rate
xenogen
graft
import
event
gener
graft
reject
outlin
fig
current
immunosuppress
drug
wide
use
transplant
clinic
situat
chosen
rel
select
action
immun
system
drug
also
use
research
tool
dissect
mechan
regul
immun
respons
firstli
azathioprin
wide
use
immunosuppress
antimitot
substanc
block
clonal
expans
activ
lymphocyt
also
affect
rapidli
divid
cell
therefor
bone
marrow
toxic
secondli
anoth
commonli
use
immunosuppress
drug
cyclosporin
toxic
bone
marrow
although
use
wide
success
exact
mechan
action
cyclosporin
major
immunosuppress
effect
probabl
blockad
express
high
affin
receptor
product
yifn
also
directli
inhibit
high
affin
receptor
alreadi
express
helper
tcell
killer
tcell
cyclosporin
explain
cyclosporin
interfer
effector
cell
function
cyclosporin
also
report
suppress
induct
mhc
class
ii
express
graft
tissu
inhibit
yifn
thirdli
steroid
may
use
particularli
combin
either
cyclosporin
azathioprin
steroid
sever
effect
beyond
scope
review
metabol
electrolyt
balanc
regul
direct
hormon
effect
action
membran
vasculatur
major
role
steroid
immunosuppress
antiinflammatori
effect
exact
mechan
antiinflammatori
effect
fulli
known
factor
particular
interest
block
activ
phospholipas
regulatori
enzym
step
foation
prostaglandin
thromboxan
leukotrien
arachidon
acid
immunosuppress
action
steroid
increas
direct
kill
immatur
tcell
resid
downregul
mainli
mhc
class
suppress
immunoglobulin
product
circul
lymphocyt
strict
control
precursor
tcell
form
bone
marrow
migrat
thymu
matur
bcell
bone
marrow
matur
tcell
releas
thymu
eventu
migrat
lymphat
tissu
lymph
node
peyer
patch
gut
spleen
band
tcell
retain
tissu
surfac
structur
call
home
receptor
activ
foreign
antigen
lymphat
tissu
lymphocyt
lose
affin
home
structur
enter
blood
activ
cell
known
accumul
brain
affect
special
kind
home
receptor
activ
lymphocyt
ubiquin
glycoprotein
induc
yifn
inflam
tissu
exampl
synovi
membran
arthrit
joint
cell
inflam
tissu
cell
expos
yifn
seen
express
anoth
molecul
icami
increas
adher
cell
immun
system
express
mhc
class
ii
endotheli
cell
tissu
mhc
class
ii
normal
express
also
propos
act
stimulu
home
possibl
exist
similar
home
signal
brain
unknown
concept
immunolog
privileg
statu
brain
refer
empir
find
allogen
xenogen
tissu
see
tabl
definit
exhibit
profong
survivaf
higher
rate
surviv
given
time
graft
brain
parenchyma
comparison
graft
peripher
site
mean
immun
reaction
take
place
brain
impli
perman
graft
surviv
immunogenetit
incompat
tissu
classic
review
barker
billingham
state
graft
way
partial
fulli
exempt
normal
rigor
impos
histoincompat
statu
thu
graft
privileg
site
constitut
except
normal
transplant
law
tabl
vi
list
select
experi
show
prolong
graft
surviv
brain
compar
graft
surviv
peripher
site
prior
develop
vitro
cultur
techniqu
need
find
hospit
site
experiment
graft
order
studi
develop
embryon
tissu
tumor
brain
identifi
one
potenti
interest
site
immedi
classifi
particularli
good
transplant
del
contess
graft
varieti
nonneurun
fetal
tissu
cerebr
cortex
adult
dog
minor
success
howev
best
found
partial
surviv
certain
type
tissu
conclud
brain
unfavor
site
im
plantat
type
fetal
tissu
came
knowledg
first
report
success
intracerebr
graft
allogen
tumor
thu
identifi
brain
suitabl
site
studi
transplant
studi
mention
ref
sinc
mani
report
publish
report
allogen
xenogen
tumor
grow
brain
eg
ref
studi
directli
compar
graft
ident
tissu
within
outsid
brain
thu
issu
brain
particularli
good
transplant
site
directli
address
nevertheless
often
remark
tumor
grew
graft
brain
thompson
earli
claim
surviv
xenograft
adult
neuron
disput
recent
work
clearli
indic
graft
adult
neuron
unlik
surviv
fact
first
report
reliabl
show
neuron
tissu
could
surviv
graft
brain
dunn
involv
immatur
cortic
tissu
graft
rat
first
report
success
graft
fetal
tissu
brain
publish
willi
studi
graft
variou
mostli
minc
whole
bodi
part
conduct
allograft
combin
rat
age
fetal
tissu
deem
import
conclud
brain
favor
site
differenti
develop
embryon
tissu
matur
tissu
without
host
resist
reaction
differenti
develop
fetal
tissu
occur
graft
subcutan
site
concern
graft
neuron
tissu
import
use
immatur
donor
repeatedli
confirm
follow
earli
find
dun
le
gro
found
good
surviv
fetal
cortic
graft
implant
intracerebr
rodent
recent
work
demonstr
donor
age
limit
crucial
factor
graft
neuron
tissu
brain
furthermor
sever
type
nonneuron
adult
tissu
parathyroid
gland
thyroid
adren
endocrin
l
pituitari
sinc
also
success
graft
brain
recent
also
sever
report
tumor
cell
line
neuroblastoma
cell
line
graft
cell
line
complet
lack
express
mhc
molecul
thu
make
iassificatiu
alloand
xenogen
graft
somewhat
difficuft
summari
sever
differ
type
tissu
surviv
graft
brain
neuron
tissu
display
surviv
immatur
wherea
develop
stage
nonneuron
tissu
seem
less
critic
graft
tumor
nonneuron
tissu
may
ideal
approach
studi
immunoiogicaili
privileg
statu
brain
direct
relev
neuron
graft
context
question
exampl
unlik
neuron
graft
nonneuron
graft
tissu
form
bloodbrain
moreov
conceiv
malign
cell
may
outgrow
host
immun
respons
despit
exist
true
immunolog
respons
perhap
via
vivo
select
tumor
ceil
express
littl
low
level
transplant
antignss
addit
f
tumor
may
less
vascular
normal
tissu
therefor
rel
inaccess
immun
altern
tumor
may
thrive
brain
achiev
high
surviv
rate
rel
better
blood
suppli
better
access
growth
factor
brain
compar
peripher
liter
tissu
differ
antigen
properti
arbitrarili
group
tissu
high
low
immunagen
antigen
affect
outcom
transplant
tabl
vi
howev
import
note
transform
low
high
immunogeni
occur
exposur
mhc
class
class
ii
antigen
induct
factor
see
section
even
tissu
time
graft
may
express
low
level
donor
may
later
express
high
level
mhc
antigen
graft
rel
abund
antigenpres
cell
graft
tissu
may
also
import
factof
govern
immunogen
tissu
cartilag
aceliufar
bone
defin
mrnunoioaiiy
privileg
tissu
tissu
except
low
immunogen
appear
evok
immun
respons
transplant
summari
evalu
graft
surviv
privileg
site
import
considerlh
genet
origin
donor
tissu
also
take
account
properti
graft
tissu
inher
particular
cellular
composit
sever
attempt
made
defin
immunogenet
basi
surviv
intracerebr
graft
order
determin
number
mhc
nonmhc
structur
may
differ
donor
host
still
allow
good
graft
surviv
heterotop
graft
exampl
good
graft
surviv
profong
period
xenogenei
adren
medulla
graft
brain
caviti
heterograft
aliogen
tissu
high
low
immunogen
surviv
prolong
time
geyer
gill
indic
heterolog
allogen
graft
place
brain
parenchyma
surviv
prolong
time
howev
mhc
class
structur
found
immun
host
sign
reject
graft
mhc
class
differ
donor
xenogen
neuron
graft
implant
brain
parenchyma
ventricl
gener
surviv
transplant
perman
although
reject
occur
larg
proport
animai
still
report
good
xenograft
surviv
fong
time
period
subset
recipi
neuron
graft
combin
interest
clinic
context
combin
mhc
nonmhc
antigen
differ
donor
host
graft
seen
surviv
week
without
sign
reject
graft
cell
suspens
parenchyma
neurona
graft
differ
oniy
mhc
class
antigen
surviv
minimum
week
parenchyma
howev
similar
intraventricular
graft
found
undergo
reject
within
week
major
graft
differ
mhc
class
ii
shown
surviv
day
parenhyma
similarli
graft
differ
nonmik
antigen
shown
good
surviv
parenhyma
summari
seem
singl
certain
immunogenet
combin
donor
host
exempt
immunolog
reject
yet
strong
evid
certain
immuuogenti
differ
donor
host
altow
indefinit
perman
graft
surviv
complet
without
immunolog
reaction
graft
implant
brain
contrast
surviv
neural
nonneur
graft
possibl
relat
degre
mhc
antigen
express
see
section
mere
quantit
differ
graft
surviv
brain
compar
site
come
length
graft
surviv
rel
strength
antigeni
differ
donor
host
propos
affer
arc
immun
system
compris
event
lead
initi
immunolog
reaction
includ
drainag
antigen
either
free
cellbound
transpiant
site
lymphat
tissu
subsequ
activ
immun
system
import
role
region
lymphat
tissu
graft
reject
repeatedli
stress
transplant
immunolog
remov
regionai
lymph
node
cios
site
grag
may
alfow
prolong
graft
surviv
aithongh
reject
still
occur
f
b
common
explan
given
prolong
surviv
time
graft
brain
lack
lymphat
inde
endotheliumlin
lymphat
vessel
normal
neuron
tissu
howev
perivascular
space
present
along
larger
vessel
brain
suggest
serv
equival
lymphat
brain
lack
classic
lymphat
vessel
brain
mean
rout
antigen
brain
reach
region
lymphat
tissu
tracer
substanc
inject
brain
parenchyma
pass
deep
cervic
lymph
node
speci
test
fraction
tracer
substanc
recov
lymph
node
partli
depend
molecular
weight
tracer
substanez
charg
tracer
particiesm
speci
use
intracerebr
inject
antigen
specif
antibodi
cell
direct
antigen
prolifer
deep
cervic
lymph
node
peak
day
particl
estim
clear
via
lymphat
inject
caudat
nucfeu
passag
extracellular
found
perivascular
space
drain
subarachnoid
space
along
white
matter
fiber
bundl
toward
olfactori
bulb
particl
final
pass
cribriform
lamina
lymphat
vessel
nasal
exist
potenti
role
rout
passag
human
remain
determin
addit
rout
extens
network
lymphat
vessel
meningi
tissu
dura
anim
model
chronic
inflammatori
condit
chronic
relaps
experiment
encephalomyel
multipl
sclerosi
human
organ
region
perivascular
space
tissu
resem
actual
iymphat
node
observ
format
implic
drainag
interstiti
fluid
present
antigen
final
mention
direct
activ
lymphocyt
circul
blood
vessel
graft
suggest
import
late
reject
alymphat
howev
due
complex
pattern
cellular
interact
normal
immun
system
rout
immun
today
regard
lesser
import
one
import
compon
affer
arc
immun
system
antigen
present
process
bring
antigen
cell
immun
system
togeth
result
activ
lymphocyt
sever
accessor
cell
immun
system
capac
summar
tabl
iiib
one
accessori
cell
dendrit
cell
nonphagocyt
cell
bone
marrow
origin
present
antigen
lymphocyt
dendrit
cell
also
express
high
level
mhc
class
ii
antigen
presenc
brain
debat
howev
head
griffin
found
mhc
class
ii
express
cell
might
dendrit
cell
line
ependyma
local
along
major
vessel
white
matter
rat
j
anoth
cell
popul
interest
alleg
resid
macrophag
brain
microglia
probabl
also
bone
marrow
origin
microglia
phagocytot
capac
resembl
macrophag
tissu
sinc
produc
activ
cell
major
cell
compon
express
mhc
class
antigen
within
brainlo
normal
constitut
glial
cell
white
matter
human
furthermor
cultur
astrocyt
produc
ill
exposur
endotoxin
iipopolysaccharid
vitro
subset
astrocyt
may
express
high
level
mhc
class
ii
antigen
exposur
yifn
stimul
astrocyt
found
capabl
present
antigen
tcell
line
promot
tcell
clonal
growth
vitro
thu
may
function
facult
antigenpres
cell
cerebr
endotheli
cell
also
propos
act
antigenpres
cell
certain
situat
cell
shown
express
mhc
class
ii
antigen
human
cerebr
vessel
activ
inflamm
site
case
multipl
sclerosi
system
lupu
erythematosu
sle
anim
experi
antigen
inject
brain
parenchyma
found
travers
endothelium
resid
lumin
side
endothelium
suggest
endotheli
cell
may
bound
antigen
surfac
cultur
cerebr
endotheli
cell
also
shown
present
brainspecif
antigen
associ
mhc
class
ii
molecul
promot
clonal
growth
specif
tcell
clone
reactiv
brainspecif
antigen
summari
sever
cell
present
brain
potenti
act
antigenpres
cell
transplant
situat
exclus
cell
antigenpres
capac
graft
tissu
prior
transplant
may
provid
mean
reduc
immun
respons
prolong
graft
surviv
mention
earlier
common
belief
previous
brain
complet
lack
lymphat
drainag
also
taken
grant
interstiti
fluid
brain
drain
complet
cerebrospin
fluid
csf
turn
drain
directli
blood
therefor
reason
antigen
introduc
brain
releas
blood
stream
vascular
rout
intracerebr
graft
antigen
present
suggest
induc
state
unrespons
accident
inject
graft
tissu
blood
stream
actual
implant
probabl
regard
behav
similar
way
incompat
graft
implant
anterior
chamber
eye
report
promptli
reject
host
spleen
remov
prior
graft
surgeri
wherea
prolong
graft
surviv
seen
spleen
left
intact
two
differ
concept
suggest
caus
immun
deviat
phenomenon
call
enhanc
tsuppressor
theori
enhanc
antibodi
immunoglobulin
bind
transplant
antigen
hide
effect
cellmedi
graft
reject
antigen
present
therebi
prolong
graft
surviv
streilein
et
suggest
suppressor
tcell
resid
spleen
downregul
immun
respons
graft
place
privileg
site
howev
point
earlier
know
brain
rodent
total
lack
passag
lymphat
moreov
recent
studi
indic
antigen
csf
pick
present
cell
choroid
plexu
therefor
emphasi
spleen
preferenti
vascular
rout
antigen
present
immunolog
privileg
may
overr
activ
immun
system
final
outcom
affer
arc
thu
immun
graft
recipi
indic
affer
arc
oper
essenti
determin
graft
tissu
immunogen
fetal
neuron
tissu
normal
express
mhc
antigen
time
graft
graft
nonprivileg
site
vigor
reject
observ
indic
fetal
neuron
tissu
sensit
technic
difficult
way
determin
anim
immun
graft
measur
surviv
time
subsequ
homotop
skin
graft
donor
strain
host
becom
sensit
skin
graft
reject
rapidli
second
set
fashion
contrast
slower
first
set
reaction
make
analysi
xenograft
particularli
difficult
sinc
primari
graft
surviv
often
poor
absenc
format
regular
blood
suppli
primari
xenogen
skin
graft
thu
rare
surviv
day
use
techniqu
homotop
skin
graft
geyer
monitor
immun
due
singl
intracerebr
allogen
skin
graft
emphas
import
mhc
class
antigen
differ
evok
immun
head
et
report
surviv
time
day
second
skin
graft
intracerebr
graft
howev
claim
short
time
normal
first
set
reaction
particular
strain
combin
author
consid
proof
host
lund
et
al
report
second
set
reaction
rat
receiv
neuron
intracerebr
xenograft
neonat
period
receiv
skin
graft
adult
anoth
test
measur
cellular
respons
follow
immun
prime
lymphocyt
test
base
appear
swifter
prolif
respons
previous
activ
lymphocyt
reexpos
antigen
stimulu
raju
grogan
found
reactiv
host
receiv
intracerebr
allogen
skin
simonsen
test
alloimmun
altern
sensit
method
measur
host
sensit
cell
viva
test
determin
prolifer
capac
lymphocyt
anim
expos
given
transplant
antigen
combin
vivo
host
immun
graft
lymphocyt
transfer
neonat
anim
donorhost
recipi
combin
prolifer
vigor
cell
reexpos
antigen
test
among
sensit
immun
assay
avail
requir
use
highli
inbr
strain
test
monitor
immun
sever
combin
allogen
fetal
neuron
even
though
antibodi
play
major
role
actual
graft
reject
common
techniqu
monitor
immun
graft
determin
titer
antibodi
form
graft
tissu
method
advantag
use
immunosuppress
anim
pure
qualit
test
import
emphas
correl
amount
antibodi
form
state
antigraft
intraparenchym
allogen
skin
intraventricular
allogen
neuron
graft
found
caus
antibodi
product
recipi
recent
found
graftspecif
antibodi
immunosuppress
rat
receiv
intrastriat
implant
fetal
human
mous
neuron
tissu
use
indirect
fluoresc
antibodi
detect
bound
rat
immunoglobulin
direct
graft
summar
sever
studi
indic
graft
place
brain
immun
host
thu
form
affer
arc
brain
immun
system
must
present
effer
arc
immun
system
compris
effector
mechan
immunolog
reaction
result
elimin
graft
cell
mainten
homeostasi
intern
milieu
brain
essenti
normal
brain
function
partial
depend
bloodbrain
barrier
complex
import
compon
complex
cerebr
capillari
endothelium
surfac
area
within
brain
time
larger
intracerebr
notabl
barrier
complex
also
compris
interstiti
barrier
socal
bloodbrain
barrierfre
region
piavessel
adventiti
barrier
choroid
plexu
pitheiiumventricuiar
system
barrier
final
bloodmening
barrier
thu
compon
contribut
effect
shield
brain
tissu
direct
contact
blood
review
see
ref
factor
contribut
restrict
passag
across
endothelium
cerebr
micravessel
zonula
occluden
compon
tight
junction
transcellular
potenti
differ
enzvmat
setup
degrad
eg
mani
potent
plasmaderiv
put
neurotransmitt
substanc
pinocytot
capac
reduc
respons
inammatori
mediat
normal
increas
permeabilityh
q
gener
substanc
normal
reudili
pass
barrier
system
highli
lipophil
uncharg
rel
smallx
cerebr
endothelium
promot
transport
desir
substanc
glucos
certain
amino
acid
chemic
gradient
transport
barrier
function
mention
earlier
partial
energydepend
rat
brain
microvessel
endotheli
cell
contain
higher
number
mitochondria
endothefi
cell
reflect
high
energi
demand
thu
protein
cell
immun
system
pass
barrier
normal
condit
may
abnorm
condit
virus
may
transport
brain
conjunct
lymphocyt
v
fact
activ
helper
tcell
recent
report
cross
intact
bloodbrain
barrier
studi
also
report
longliv
antigenspecif
lymphocyt
activ
state
pass
barrier
even
administ
high
numbersi
passag
thought
mainli
mediat
lymphocyt
properti
degrad
enzym
produc
activ
lymphocyt
howev
passag
activ
lymphocyt
brain
seem
confin
postcapillari
venul
therefor
factor
vessel
properti
home
receptor
may
well
involv
multipi
sclerosi
patient
tce
labef
fluoresc
antibodi
inject
blood
recov
cs
bcell
also
pass
barrier
csf
ms
patient
illustr
fact
system
immun
tetanu
toxoid
bcell
produc
antitetanu
immunogobuiin
recov
csfzo
howev
import
stress
ms
patient
possess
normal
barrier
complex
exhibit
abnorm
mhc
class
ii
express
cerebr
vessel
consid
contribut
barrier
immunolog
privileg
statu
brain
import
rememb
highli
immunogen
tissu
skin
form
barrier
complex
still
exhibit
prolong
surviv
graft
brain
indic
bloodbrain
barrier
sote
cntributor
immunotogicatfi
privileg
statu
brain
fn
summari
wherea
brood
rain
barrier
previous
thought
constitut
complet
barrier
compon
immun
system
today
evid
limit
passag
immunocompet
cell
certain
condit
earli
murphi
propos
brain
could
produc
substanc
suppress
immun
reaction
howev
still
exist
littl
experiment
evid
support
hypothesi
glucocorticosteroid
ufetoprotein
prostaglandin
e
well
establish
regul
mhc
cfass
ii
antigen
express
could
theoreticafli
act
local
immunosuppr
sive
factor
brain
interestingli
astrocyt
shown
vitro
produc
prostaglandin
ez
ref
whether
play
signific
physiologicat
role
unknown
observ
indic
activ
iymphoid
cell
may
confin
perivascufar
space
postcapiiari
venuf
brain
without
migrat
parenchyma
could
suggest
brain
parenchyma
produc
substanc
hinder
local
lymphocyt
migrat
kept
mind
certain
circumst
lesion
brain
affect
system
immun
interrupt
hypothalamicpin
tuitari
axi
particip
regul
hormon
level
system
circul
pronounc
lesion
place
pituitari
hypothalamu
anterior
howev
larg
major
graft
experi
brain
lesion
relev
also
shown
produc
qand
plike
ifn
activ
respons
standard
ifninduc
agent
vitro
al
like
ifn
produc
shown
induc
high
level
mhc
class
antigen
express
subset
mous
astrocyt
similar
condit
astrocyt
cerebr
endothelium
also
shown
abl
express
high
level
mhc
class
ii
recent
paper
mason
et
al
nichola
et
al
found
fetal
neuron
tissu
graft
ventricular
system
express
high
level
mhc
antigen
undergo
reject
increas
cell
surfac
mhc
express
also
observ
graft
neuron
tissu
syngen
transplantationi
suggest
inflammatori
respons
caus
mere
surgic
trauma
suffici
induc
increas
mhc
antigen
express
fetal
neuron
tissu
exact
mediat
mhc
induct
classic
inflamm
known
could
includ
mention
previous
presenc
mhc
molecul
prime
import
immunologica
reaction
nichola
et
report
preferenti
neuron
cell
surviv
reject
graft
suggest
cell
express
lower
level
mhc
surround
nonneuron
cell
within
graft
parenchyma
consequ
low
mhc
express
illustr
transfer
activ
killer
tcell
direct
lymphochoriomening
lcm
virusinfect
cell
lcm
virustoler
anim
neonataili
infect
lcm
viru
cell
bodi
express
lcm
viral
antigen
associ
mhc
kill
within
two
week
lcminfect
brain
cell
express
mhc
therefor
still
remain
aliv
mhc
antigen
appear
brain
cell
induct
turnov
rate
mhc
molecul
particular
interest
unfortun
littl
known
stabil
mhc
antigen
brain
cell
express
origin
induct
stimulu
subsid
studi
cell
type
suggest
halflif
mhc
molecul
viral
induct
may
rel
short
rang
cerebr
endotheli
cell
induc
express
mhc
class
ii
molecul
vivo
endothelium
subsequ
isol
induct
agent
mhc
class
ii
antigen
found
cell
surfac
h
later
vitro
tabl
vii
summar
brain
tissu
cell
express
mhc
antigen
effect
induct
agent
mhc
antigen
express
first
record
trial
involv
graft
neuron
tissu
across
speci
barrier
stem
almost
centuri
ago
thompson
report
cortic
tissu
graft
cat
dog
vice
versa
surviv
xenograft
case
two
anim
studi
maximum
day
graft
surviv
therefor
result
difficult
interpret
view
present
knowledg
gener
condit
requir
surviv
neuron
graft
like
third
anim
studi
week
transplant
contain
remnant
resorb
graft
tissu
although
sever
success
intracerebr
graft
studi
follow
first
half
centuri
see
section
past
year
surviv
alloand
xenograft
neuron
tissu
specif
address
studi
shown
surviv
intracerebr
neuron
alloand
xenograft
reduc
compar
syngen
transplant
nevertheless
certain
circumst
possibl
neuron
alioand
xenograft
surviv
function
prolong
period
without
immunosuppress
adult
rodent
brain
parenchyma
systemat
experi
histoincompat
neuron
graft
conduct
mainli
two
anatom
site
striatum
hippocampu
see
section
extraparenchym
intraventricular
graft
dealt
separ
section
immunolog
reaction
site
may
quit
differ
intracerebr
site
da
neuron
found
surviv
well
graft
rat
fetus
adult
rat
striatum
model
direct
relev
model
graft
recipi
first
given
uniiater
lesion
mesostriat
da
pathway
use
neurotoxin
ghydroxydopamin
bohda
result
aa
easili
quantifi
motor
first
xenograft
studi
solid
piec
fetal
mous
mesencephal
tissu
place
cortic
caviti
overli
caudateputamen
case
surviv
ra
neuron
found
either
graft
tissu
cortic
caviti
case
scatter
cell
migrat
caudteputamen
proper
subsequ
studi
use
cell
suspens
techniqu
xenograft
mous
da
neuron
surviv
rat
howev
use
techniqu
surviv
graft
rat
may
indic
occur
timerel
continu
loss
xenograft
similarli
xenograft
rabbit
fetal
mesencephai
ceil
shown
poor
surviv
without
immunosuppress
recent
experi
shown
fetal
ailograft
contain
da
neuron
surviv
intraparenchym
graft
striatum
adult
without
use
immunosuppress
prior
graft
primat
recipi
inject
da
neurotoxin
ptp
result
sever
parkinsonian
symptom
best
case
neurolog
deficit
clearli
reduc
transplant
human
fetal
mesencephal
tissu
differ
age
also
graft
rat
immunosuppress
cyclosporin
studi
util
cell
suspens
techniqu
good
survivat
da
neuron
obtain
graft
tissu
taken
old
younger
fetus
wherea
older
tissu
yield
poor
da
neuron
presum
relat
similar
donorag
restrict
found
use
rat
fetal
donor
contrast
good
surviv
cyclosporin
atreat
rat
graft
surviv
week
human
da
neuron
implant
nonmmunosuppress
rat
wowev
kamo
et
al
report
cultur
fetal
human
spinal
cord
c
ceil
fetal
human
sympathet
surviv
graft
striatum
cortic
caviti
sever
week
even
nonimmuo
suppress
rat
use
cell
suspens
techniqu
mous
septal
tissu
rich
cholinerg
neuron
success
xenograft
rat
hippocampu
week
postgraft
surviv
rate
estim
approxim
rat
surviv
xenograft
restor
normal
hippocamp
acetylcholinesteras
lamin
patterr
cholin
acetyltransferas
partial
revers
lesioninduc
deficit
condit
learn
interestingli
cell
suspens
implant
difficult
imposs
discern
discret
tissu
mass
surviv
graft
identifi
scatter
acetylcholinesteraseposit
cell
exist
acetylcholinesteraseposit
stain
fiber
host
hippocampu
allogen
set
graft
solid
basal
forebrain
tissu
display
approxim
surviv
rate
place
caviti
adjac
experi
allogen
xenogen
graft
hippocampu
summar
tabl
viiib
surviv
graft
ventricular
system
might
somewhat
differ
intraparenchym
graft
therefor
result
graft
place
ventricular
system
treat
separ
tabl
viiic
list
exampl
allogen
xenogen
graft
place
ventricular
system
frequenc
surviv
xenograft
rat
vari
fetal
mous
cortic
adult
bovin
adren
variat
allogen
graft
surviv
likewis
larg
one
particular
graft
combin
fetal
cortic
graft
suspens
solid
graft
differ
mhc
nonmhc
antigen
graft
incomplet
histoincompat
day
immunosuppress
drug
cyclosporin
mgkg
daili
lp
markedli
increas
surviv
cell
suspens
graft
mous
da
neuron
implant
rat
striatum
initi
studi
immunosuppress
rat
exhibit
behavior
function
graft
larg
number
surviv
da
neuron
week
transplant
wherea
nonimmunosuppress
control
rat
possess
small
surviv
cyclosporin
also
found
increas
surviv
intraparenchym
xenograft
rabbit
da
neuron
mous
hippocamp
tissu
cortic
mous
graft
place
ventricular
system
rat
initi
studi
two
rat
cyclosporin
atreat
group
studi
week
respect
termin
immunosuppress
period
rat
retain
larg
graft
rich
da
neuron
remain
find
prompt
us
investig
shortterm
cyclosporin
treatment
could
support
longterm
surviv
intracerebr
da
graft
use
model
graft
fetal
mous
mesencephalit
tissu
rat
receiv
immunosuppress
alloc
either
lo
cyclosporin
treatment
scheme
three
week
transplant
sever
rat
cyclosporin
atreat
group
show
expect
behavior
evid
surviv
function
transplant
howev
week
cessat
respect
cyclosporin
treatment
major
rat
exhibit
evid
reject
loss
behavior
graft
effect
thu
morpholog
analysi
month
transplant
larg
major
immunosuppress
rat
lack
surviv
graft
suggest
shortterm
immunosuppress
treatment
reliabl
support
longterm
surviv
intrastriat
fetal
da
cell
suspens
graft
mice
rat
antigen
fetal
neuron
tissu
relat
development
stage
mode
tissu
prepar
cellular
compon
graft
cell
surfac
structur
fetal
neuron
cell
use
transplant
systemat
studi
care
separ
neuron
tissu
overli
mesenchym
cover
larg
remov
pleuripot
mesenchym
cell
hematopoiet
cell
stem
cell
potenti
develop
nonneuron
tissu
express
mhc
antigen
therebi
graft
tissu
consist
mainli
matur
neuron
glial
cell
cell
respect
precursor
follow
dissect
tissu
implant
either
solid
piec
inject
cell
suspens
normal
low
level
mhc
class
ii
molecul
express
neuroand
glioblast
graft
development
stage
trypsin
treatment
sometim
use
prepar
cell
suspens
thu
unlik
affect
mhc
express
human
mhc
molecul
trypsinsensit
wherea
mous
mhc
degrad
trypsin
suffici
high
concentr
enzym
use
contrast
vascular
endothelium
express
class
antigen
certain
condit
may
also
express
class
ii
mhc
antigen
like
fetal
neuroblast
express
potenti
polymorph
molecul
thi
ref
cell
adhes
speciesspecif
cell
surfac
notabl
solid
graft
differ
thi
molecul
minor
transplant
antigen
surviv
implant
mous
cerebellum
day
without
histolog
sign
moreov
import
rememb
cell
graft
tissu
stimul
express
transplant
antigen
graft
surgeri
discuss
earlier
fetal
neuron
tissu
also
shown
capabl
immun
host
intracerebr
graft
see
section
caus
reject
prior
intracerebr
graft
graft
kidney
inject
l
volum
cell
suspens
rat
brain
caus
transient
breakag
bloodbrain
follow
local
edema
initi
graft
cell
probabl
depend
diffus
distant
blood
vessel
nutrit
solid
tissu
piec
graft
either
heterotop
origin
eg
skin
graft
homotop
origin
like
differ
cell
suspens
graft
regard
origin
vessel
graft
time
cours
revascular
skin
graft
prepar
way
contain
intact
vessel
graft
vascular
day
transplant
primordi
vessel
graft
tissu
develop
capillari
larger
vessel
within
graft
skin
tissu
vessel
seemingli
hook
host
vessel
grafthost
process
found
oper
solid
embryon
neuron
graft
place
third
origin
vessel
seem
vari
neuron
cell
suspens
graft
cell
vessel
come
host
other
deriv
graft
tissu
origin
vasculatur
graft
may
great
import
sinc
endotheii
line
blood
vessel
express
high
level
donor
mhc
may
first
site
attack
immun
respons
graft
inflammatori
mediat
angiogen
properti
particip
revascular
exampl
ill
releas
activ
astrocyt
macrophag
induc
prolifer
endotheli
sever
specif
endotheli
growth
factor
isol
brain
tissu
establish
bloodbrain
barrier
time
cours
develop
graft
may
import
surviv
graft
although
lymphocyt
certain
activ
stage
pass
barrier
passag
lymphocyt
may
still
remain
restrict
interestingli
vessel
peripher
tissu
graft
brain
form
intact
bloodbrain
wherea
cn
tissu
graft
peripheri
attain
function
bloodbrain
barrier
hypothes
glial
cell
surround
vessel
induc
bloodbrain
barrier
idea
support
studi
purifi
astrocyt
inject
anterior
chamber
eye
vessel
iri
invad
aggreg
astrocyt
form
bloodbrain
barrier
properti
typic
tight
junction
vessel
exclud
macromolecular
tracer
slightli
conflict
result
obtain
studi
develop
bloodbrain
barrier
intracerebr
neuron
graft
describ
incomplet
barrier
leak
macromolecular
tracer
horseradish
peroxidas
endogen
protein
sever
week
graft
solid
fetal
neonat
neuron
tissu
cortex
fourth
ventricl
contrast
broadwel
et
demonstr
intact
bloodbrain
barrier
solid
fetal
neuron
graft
place
third
ventricl
mice
day
revascular
occur
moreov
recent
found
vessel
intrastriat
cell
suspens
graft
rat
attain
low
permeabl
evan
bluelabel
macromolecul
within
day
graft
similar
result
tight
bloodbrain
barrier
macromolecul
found
solid
fetal
graft
hippocampu
cell
suspens
graft
thalamu
final
intracort
solid
graft
neonat
rat
summari
would
seem
fetal
neuron
tissu
graft
form
bloodbrain
barrier
macromolecul
situat
howev
remain
unclear
whether
develop
intact
bloodbrain
barrier
play
import
role
hinder
limit
immun
respons
intracerebr
graft
inevit
surgic
trauma
evok
inflammatori
respons
brain
around
implant
site
host
vessel
like
disrupt
unleash
coagul
cascad
aggreg
thrombocyt
debri
disrupt
dead
cell
graft
probabl
clear
area
phagocytos
cell
resid
microglia
bloodderiv
macrophag
monocyt
process
multitud
differ
inflammatori
mediat
like
releas
effect
inflammatori
mediat
permeabl
across
cerebr
endothelium
effect
blood
flow
known
detail
although
effect
like
less
mark
peripher
circul
sinc
cerebr
vessel
lack
receptor
sever
permeabl
vasoact
inflammatori
mediat
may
releas
endotheli
cell
resid
astrocyt
invad
cell
platelet
monocyt
transplant
situat
inflammatori
mediat
affect
express
mhc
antigen
endotheli
cell
orthotop
skin
graft
undergo
reject
express
higher
level
mhc
class
antigen
stimul
express
class
ii
mention
previous
normal
low
level
mhc
express
slightli
elev
graft
cn
tissu
even
syngen
graft
combin
one
possibl
candid
inflammatori
induct
signal
plateletderiv
growth
factor
pdgf
shown
induc
mhc
antigen
express
bcell
releas
aggreg
platelet
activ
monocyt
candid
astrocytederiv
ifnlik
substanc
recent
anoth
import
step
inflammatori
respons
may
releas
ill
produc
either
resid
astrocyt
microglia
invad
monocyt
strongli
lymphotacti
induc
migrat
prolifer
astrocyt
see
plateletderiv
inflammatori
mediat
coagul
complement
cascad
may
produc
mediat
activ
stimulu
macrophag
activ
ia
phagocytosi
injuri
immunolog
factor
immun
complex
yifn
endothelium
glia
cell
also
abl
produc
mediat
take
part
inflammatori
event
eg
lymphotaxi
cell
lymphocyt
peak
graft
area
observ
mhc
express
cellular
infilthird
week
xenogen
solid
neuron
graft
trate
mous
retin
xenograft
implant
neoplac
hippocampu
l
lymphocyt
also
natal
rat
lymphocyt
infiltr
peak
graft
present
mening
choroid
plexu
degener
evid
day
particperivascular
space
follow
reject
process
inularli
promin
perivascular
space
duce
orthotop
skin
graft
houston
et
al
surround
host
brain
observ
tcellspecif
immunosuppress
drug
cyclosporin
discuss
section
increas
surviv
xenogen
graft
also
support
notion
tcell
mediat
immunolog
reaction
compris
crucial
compon
graft
reject
also
brain
absenc
lymphocyt
around
graft
necessarili
impli
immunolog
reaction
taken
place
exclud
slow
ongo
chronic
reject
even
fetal
neuron
graft
necessari
stimuli
reject
seem
present
long
time
period
rat
receiv
intrastriat
xenograft
exampl
xenograft
gener
reject
within
week
withdraw
therapeut
late
reject
may
initi
due
presenc
foreign
endotheiium
vasculatur
could
provid
chronic
stimulu
host
immun
system
would
lead
high
number
circul
graftspecif
activ
lymphocyt
similarli
well
integr
allograft
surviv
prolong
period
may
risk
reject
inflamm
unrel
activ
immun
system
would
subsequ
increas
mhc
express
vessel
graft
tissu
immun
system
implic
sever
neurolog
diseas
includ
multipl
sclerosi
acut
polyradiculoneur
inflammatori
polyneur
brain
contain
sever
antigen
structur
often
regard
potent
autoantigen
notabl
myelin
basic
protein
apoprotein
experiment
model
known
experiment
allerg
enceph
eae
immun
small
octapeptid
deriv
myelin
basic
protein
suffici
caus
demyelin
diseas
specif
strain
prone
develop
date
report
similar
lesion
normal
host
nervou
tissu
due
neural
transplant
publish
notabl
tissu
use
cell
suspens
graft
taken
development
stage
contain
myelin
compon
limit
risk
eaelik
condit
releas
put
autoantigen
normal
tissu
damag
neurosurgeri
found
major
caus
demyelin
aberr
autoimmun
reaction
theoret
possibl
reject
establish
neuron
graft
could
caus
perturb
adjac
host
vasculatur
part
normal
host
brain
afflict
howev
studi
reject
function
xenograft
rat
indic
host
brain
becom
significantli
involv
topic
immunolog
toler
complex
subject
beyond
scope
review
howev
specif
immunolog
unrespons
graft
tissu
possibl
explan
intracerebr
neuron
alloand
xenograft
function
month
complet
toler
evolv
second
skin
graft
donor
perman
accept
case
studi
nichola
et
al
observ
swifter
reject
fetal
neuron
allogen
intraventricular
graft
orthotop
skin
graft
transplant
two
week
intracerebr
graft
adult
mice
toler
usual
accomplish
graft
perform
host
day
age
recent
studi
indic
good
surviv
xenogen
neuron
tissu
implant
parenchyma
possibi
host
day
postnat
xenograft
accept
day
without
sign
reject
challeng
skin
graft
reject
occur
may
exampl
partial
toler
poorli
understood
immunolog
phenomenon
one
possibl
explan
partial
toler
lymphocyt
react
strongli
first
graft
tissu
elimin
neonat
period
clone
lymphocyt
lesser
avid
may
still
present
host
clone
harm
graft
tissu
adequ
second
stimulu
orthotop
skin
graft
activ
suffici
mani
host
lymphocyt
react
graft
tissu
caus
full
reject
graft
age
graft
recipi
may
affect
immun
respons
toward
graft
tissu
variou
way
host
neonat
immatur
perman
immunolog
toler
like
occur
see
section
end
scale
also
propos
recipi
graft
old
immun
respons
may
differ
younger
individu
inde
report
literatur
indic
occur
agedepend
declin
certain
immunolog
declin
partli
speciesand
strainspecif
influenc
age
immunolog
reaction
put
role
immun
reaction
age
process
vast
subject
beyond
review
howev
report
indi
cate
reduc
graft
reject
capac
elderli
clinic
experi
transplant
elderli
support
regim
immunosuppress
use
age
individu
studi
incompat
intracerebr
neuron
graft
essenti
avoid
overestim
underestim
extent
immunolog
reject
identif
graftderiv
cell
brain
may
lead
belief
graft
reject
also
discuss
graft
low
surviv
rate
one
must
directli
compar
surviv
rate
similar
techniqu
would
yield
syngen
combin
immunosuppress
host
order
abl
defin
exact
role
immunolog
reject
major
problem
monitor
graft
fetal
neuron
tissu
lack
specif
method
demonstr
ongo
immunolog
reaction
vivo
test
avail
measur
statu
immun
system
daytoday
basi
could
reveal
increas
risk
immin
reject
organ
graft
usual
simpl
measur
function
graft
organ
avail
monitor
sign
poor
graft
function
measur
reject
episod
taken
addit
graft
biopsi
confirm
ongo
reject
support
adopt
special
measur
reject
function
test
avail
neuron
tissu
graft
graft
cell
give
rise
function
effect
gener
long
latenc
graft
surgeri
develop
function
effect
render
neuron
transplant
investig
blind
extend
time
period
immunolog
attack
may
take
place
graft
tissu
tendenc
toward
better
surviv
incompat
graft
hippocampu
compar
striatum
tabl
viiia
b
similar
suggest
differenti
graft
surviv
made
head
et
al
propos
histoincompat
skin
graft
place
occipit
lobe
surviv
better
implant
forebrain
data
unconvinc
sinc
experi
perform
rat
find
interstiti
fluid
forebrain
preferenti
drain
lymphat
fluid
hindbrain
drain
csf
may
bear
compar
fate
graft
ventricular
system
fate
intrapenchym
graft
definit
conclus
made
regard
site
hospit
graft
one
propos
intraventricular
graft
interact
host
least
two
princip
differ
manner
firstli
small
piec
graft
tissu
probabl
receiv
full
nutrit
support
cerebrospin
fluid
absenc
blood
vessel
almost
complet
reach
immun
system
might
allow
complet
surviv
across
major
histocompat
barrier
secondli
solid
graft
ventricl
seen
receiv
blood
suppli
neighbor
brain
tissu
vessel
within
solid
graft
like
complet
deriv
donor
appear
hook
host
vessel
interfac
graft
graft
tissu
greater
risk
reject
nonvascular
graft
ventricl
may
also
reject
quickli
intraparenchym
graft
might
contain
vessel
mixtur
graft
host
origin
summar
mode
tissu
prepar
site
graft
affect
neurobiolog
properti
graft
also
immunolog
statu
clinic
set
conceiv
regraft
brain
would
necessari
either
order
improv
poor
function
exist
graft
permit
reinnerv
addit
target
area
exampl
contralater
initi
graft
although
well
known
intracerebr
graft
place
sensit
host
surviv
publish
report
concern
intracerebr
regraft
allogen
xenogen
neuron
tissu
studi
repeat
intracerebr
graft
skin
incompat
donor
given
indic
second
graft
may
jeopard
surviv
success
first
seem
allograft
even
complet
histoincompat
gener
surviv
significantli
better
xenograft
brain
see
eg
tabl
viii
empir
find
conform
find
obtain
peripher
site
easili
explain
theoret
xenogen
set
host
like
possess
higher
number
clone
recogn
antigen
determin
mhc
nonmhc
structur
allogen
set
differ
xenoand
allograft
necessarili
reflect
graft
surviv
time
peripheri
immun
respons
work
unrestrict
condit
howev
differ
host
capac
recogn
graft
antigen
may
decis
factor
intracerebr
graft
surviv
implant
fetal
neu
possibl
sequenc
event
cellular
tissu
respons
intracerebr
graft
immunogenet
differ
fetal
neuron
tissu
cell
suspcnsion
healthi
adult
rodent
brain
briefli
describ
donor
tissu
prepar
newli
abort
fetus
mening
care
dissect
away
desir
neuron
region
mechan
disrupt
form
suspens
free
cell
cell
small
aggreg
stereotax
inject
brain
implant
caus
transient
iocai
edema
local
ruptur
bloodbrain
barrier
ruptur
small
vessel
evok
coagul
process
concomit
tissu
damag
give
rise
inflammatori
process
lead
activ
astrocyt
start
migrat
prolifer
activ
astrocyt
capabl
produc
angiogen
factor
possibl
ili
ifnlik
substanc
activ
astrocyt
produc
increas
amount
glial
fibrillari
protein
aggreg
monocyt
macrophag
might
microglia
like
attract
graft
area
graftderiv
cell
expos
sever
inflammatori
mediat
mhc
express
like
increas
graft
cell
high
mhc
level
express
probabl
brought
local
lymphat
tissu
either
whole
migrat
cell
piec
carri
hostderiv
defens
cell
initi
graft
surviv
diffus
nutrient
oxygen
endotheli
cell
donor
integr
vessel
grow
graft
end
ruptur
host
vessel
revascular
well
underway
within
day
week
implant
bloodbrain
barrier
reform
cell
die
graft
scaveng
invad
macrophag
resid
microglia
activ
astrocyt
antigen
graft
reach
proxim
lymphat
tissu
activ
immun
system
prolifer
lymphocyt
initi
activ
lymphocyt
releas
blood
stream
within
day
cell
circul
home
inflammatori
region
around
wound
graft
prolifer
lymphocyt
take
place
around
graft
antigen
prime
present
activ
lymphocyt
produc
increas
amount
lymphokin
increas
intens
inflamm
caus
enhanc
express
mhc
antigen
host
graft
cell
killer
tcell
homotop
tissu
neural
tissu
brain
heterotop
tissu
nonneur
tissu
brain
donor
age
depend
techniqu
use
abil
graft
tissu
surviv
hernia
abil
surviv
immedi
postop
period
durat
revascular
trophic
factorstarget
nontarget
specif
viral
infect
donor
tissu
intraand
postop
complic
eg
bleed
bacteri
infect
puriti
dissect
eg
amount
mening
graft
prepar
bloodbrain
barrier
format
autograft
syngen
ii
aspect
allogen
xenogen
factor
tissu
applic
adren
medulla
carot
bodi
factor
limit
inbr
strain
factor
addit
follow
host
age
immunolog
reaction
mhc
nonmhc
antigen
content
antigen
present
cell
graft
tissu
content
preform
vessel
precursor
vessel
degre
angiogenesi
caus
inflamm
revascular
sourc
vessel
hostor
donorderiv
durat
bloodbrain
barrier
ruptur
malfunct
degre
inflamm
caus
surgeri
respons
inflammatori
stimuli
amount
mhc
induc
vessef
brain
tissu
durat
antigen
stimulu
graft
tissu
durat
activ
lymphocyt
circul
induct
home
structur
vessel
toler
induct
site
graft
brain
factor
addit
follow
nonmhc
antigen
tend
give
rise
strong
immunoiogica
reaction
resembl
mhc
reactiv
preform
antibodi
match
trophic
factor
receptor
factor
addit
specif
host
immun
present
prior
second
graft
proceed
lyse
cell
possibl
start
graftderiv
endotheli
cell
moreov
lymphotoxin
releas
lymphocyt
macrophag
kill
cell
receptor
toxin
final
graft
tissu
less
disintegr
engulf
macrophag
partli
base
sequenc
event
present
model
graft
surviv
may
provid
tent
explan
brain
immunoloc
privileg
site
factor
thought
fulli
explain
privileg
statu
brain
absenc
lymphat
drainag
absenc
antigenpres
cell
absenc
passag
across
bloodbrain
barrier
lymphocyt
absenc
mhc
class
ii
antigen
nervou
tissu
ceil
shown
appli
within
brain
tissu
certain
condit
spite
brain
beyond
doubt
privileg
site
graft
privileg
defin
prolong
graft
surviv
compar
surviv
time
anoth
locu
reason
still
unclear
one
hypothet
explan
prolong
surviv
although
compon
necessari
normal
immun
respons
graft
reject
present
kinet
degre
regulut
individu
step
immun
respons
follow
intracerebr
graft
may
differ
peripheri
therebi
simpl
delay
immun
respons
may
result
prolongedgraft
surviv
one
postul
certain
crucial
event
mhc
express
graft
brain
cell
declin
execut
next
step
immun
reaction
passag
activ
lymphocyt
across
reform
barrier
complex
normal
chain
event
immun
reaction
irrevers
broken
result
perman
graft
surviv
one
could
therefor
regard
privileg
statu
brain
state
quantit
tempor
balanc
regul
event
control
larg
number
cellular
mediat
among
lymphokin
intercellular
commun
molecul
increas
understand
factor
underli
regul
immunolog
respons
graft
brain
across
immunolog
barrier
would
perhap
possibl
interfer
step
rel
mild
way
ensur
prolong
graft
surviv
ultim
also
clinic
set
acknowledg
would
like
thank
follow
peopl
help
discuss
suggest
erna
goran
moller
dept
clinic
immunolog
karolinska
institut
hudding
hospit
immunolog
stockholm
univers
stockholm
barbro
johansson
dept
neurolog
lund
univers
hospit
ander
bjorklund
oll
lindval
dept
medic
cell
research
lund
grate
effort
provid
sara
marshal
dublin
improv
languag
final
grate
vibek
ankjer
provid
inspir
fund
review
partli
provid
grant
swedish
msfoundat
swedish
societi
medicin
rut
erik
hardebo
foundat
acad
sci
barker
cf
billingham
role
affer
lymphat
reject
skin
homograft
exp
med
barker
cf
biffingham
immunolog
privileg
site
adv
mrnzo
betz
al
goldstein
gw
polar
blood
